Progesterone Receptor-negative Breast Cancer Completed Phase 2 Trials for Trimetrexate (DB01157)

DBCOND0028547 (Progesterone Receptor-negative Breast Cancer)Completed2 IdentifierTitlePurposeDrugs
NCT00194779Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By SurgeryTreatment
NCT00003199Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast CancerTreatment